NCAM1 and neoplasm: The impact of this binding seems to be controversial, since some studies show that CD56 expression on tumor cells makes them more sensitive for NK cell-mediated lysis [148,149], while experimental overexpression of CD56/NCAM can be protective for some tumor cell lines [150].